The South African Health News Service
Subscribe
Find a Clinic
Medicine Price Registry
Return to Content

Taking the tablets

September 25, 2003
News  

What it’€™s like to take antiretroviral therapy, how many pills are needed and why taking them regularly and consistently is so important.

Private sector vs public sector

September 25, 2003
News  

Where is the best place to take antiretrovirals ‘€“ with a private doctor or through the public sector? Many would argue the public sector is more efficient and effective.

A judge for lifeLiving with AIDS #144

September 19, 2003
News  

As the government-appointed task team on AIDS treatment works towards its end of September deadline, Health-e takes a look at what antiretroviral drugs mean to people already taking them. In the first of two parts, Justice Edwin Cameron talks about his experience of living with AIDS and six years on anti-retroviral therapy.

A journey to health

September 18, 2003
News  

Buyiswa Gcwabe is a mother of seven children and has AIDS. She is a member of the Treatment Action Campaign and is among the first group of 25 people to receive antiretroviral treatment funded by the TAC. Health-e travelled with her to her first appointment with the doctor who will monitor her treatment.

TAC launches treatment plan

September 9, 2003
News  

The Treatment Campaign Action has launched the “Treatment Project” to provide antiretroviral drugs to its most needy members. For each TAC member on ARV therapy, a non-TAC member who needs the life-prolonging drugs will be treated. Some 110 TAC members have died from AIDS related illnesses between March and July this year alone.

Explaining ARV therapy

September 9, 2003
News  

Not everyone who is HIV positive needs antiretroviral therapy. Dr Khwezi Matoti runs the AIDS clinic at the Guguletu Day Hospital and explains when antiretroviral drugs become necessary.

Achmat speaks of survival guilt

August 29, 2003
News  

Treatment Action Campaign chairperson Zackie Achmat has started antiretroviral therapy but lives with the guilt of having access to the life-prolonging drugs while fellow South Africans wait for the roll-out of ARVs in the public health setor.